US FDA sets its sights on the developing world

  • Published on
    16-Mar-2017

  • View
    212

  • Download
    0

Transcript

<ul><li><p>PharmacoEconomics &amp; Outcomes News 561 - 6 Sep 2008</p><p>US FDA sets its sights on thedeveloping world</p><p>A new US FDA proposal would see inspection officesestablished in five regions of the developing world toenable the agency to better monitor the safety of drugs,food and medical devices being exported to the US.</p><p>A funding increase was proposed recently,* for thisexpansion, with a total proposed increase in FDAfunding over the previous fiscal year now topping$US404 million, a 17.8% rise. Asia, India, CentralAmerica, South America and the Middle East are theregions targeted for the new FDA presence. Inspectionsare already carried out by the agency in Canada, with theFDA and Health Canada having an arrangement underwhich an auditor from one of the agencies conductsinspections on behalf of both: the FDA is nownegotiating a similar arrangement with the EuropeanUnion.* See PharmacoEconomics &amp; Outcomes News 560, p 10; 801108088</p><p>Kondro W. FDA goes global. CMAJ: Canadian Medical Association Journal 179:131, No. 2, 15 Jul 2008 801122194</p><p>1</p><p>PharmacoEconomics &amp; Outcomes News 6 Sep 2008 No. 5611173-5503/10/0561-0001/$14.95 Adis 2010 Springer International Publishing AG. All rights reserved</p></li></ul>